Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20010873HPVENSG00000273079.7protein_codingGRIN2BNoNo2904Q13224
TVIS20012367HPVENSG00000273079.7protein_codingGRIN2BNoNo2904Q13224
TVIS20012707HPVENSG00000273079.7protein_codingGRIN2BNoNo2904Q13224
TVIS20050596HPVENSG00000273079.7protein_codingGRIN2BNoNo2904Q13224
TVIS20050636HPVENSG00000273079.7protein_codingGRIN2BNoNo2904Q13224
TVIS20045698HPVENSG00000273079.7protein_codingGRIN2BNoNo2904Q13224
TVIS20044520HPVENSG00000273079.7protein_codingGRIN2BNoNo2904Q13224
TVIS20038432HPVENSG00000273079.7protein_codingGRIN2BNoNo2904Q13224
TVIS20043967HPVENSG00000273079.7protein_codingGRIN2BNoNo2904Q13224
TVIS44031789HTLV-1ENSG00000273079.7protein_codingGRIN2BNoNo2904Q13224
TCGA Plot Options
Drug Information
GeneGRIN2B
DrugBank IDDB06077
Drug NameLumateperone
Target IDBE0000417
UniProt IDQ13224
Regulation Type
PubMed IDs30449883
CitationsVanover KE, Davis RE, Zhou Y, Ye W, Brasic JR, Gapasin L, Saillard J, Weingart M, Litman RE, Mates S, Wong DF: Dopamine D2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia. Neuropsychopharmacology. 2019 Feb;44(3):598-605. doi: 10.1038/s41386-018-0251-1. Epub 2018 Oct 26.
GroupsApproved; Investigational
Direct ClassificationAlkyl-phenylketones
SMILES[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=CC=CC3=C1N2CCN3C
Pathways
PharmGKB
ChEMBLCHEMBL3306803